Atlas Trials

Bioequivalence of a Test Troche Formulation of Fentanyl Citrate (400 mcg) Compared to Actiq® 400 mcg, Cephalon, Inc.

Clinical trial NCT01173627 · COMPLETED

Trial details

NCT number
NCT01173627
Sponsor
Mallinckrodt
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pain
Start date
2006-08-01
Primary completion
2006-08-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.